Legendre L'insuffisance rénale chronique : prévention et traitement ,
Principes physico-chimiques de la dialyse, 1994. ,
Effects of haemoglobin normalization on quality of lif e and cardiov ascular parameters in end-stage renal failure, Nephrol Dial Transplant, vol.15, pp.1425-1455, 2000. ,
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy, Kidney International, vol.58, issue.3, pp.1325-1360, 2000. ,
DOI : 10.1046/j.1523-1755.2000.00289.x
Quality of life in dialysis patients. A Spanish multicentre study, Nephrology Dialysis Transplantation, vol.11, issue.supp2, pp.125-134, 1996. ,
DOI : 10.1093/ndt/11.supp2.125
Quality of life benefits of early anaemia treatment, Nephrology Dialysis Transplantation, vol.15, issue.suppl_3, pp.23-31, 2000. ,
DOI : 10.1093/oxfordjournals.ndt.a027972
Towards long-term graft survival in renal transplantation: the role of erythropoietin, Nephrology Dialysis Transplantation, vol.10, issue.supp1, pp.20-22, 1995. ,
DOI : 10.1093/ndt/10.supp1.20
Outcome of renal transplantation in patients treated with erythropoietin ,
EFFECT OF PRETRANSPLANT ERYTHROPOIETIN THERAPY ON RENAL ALLOGRAFT OUTCOME, Transplantation, vol.62, issue.7, pp.1026-1034, 1996. ,
DOI : 10.1097/00007890-199610150-00024
Maternal and Fetal Erythropoietin: Physiological Aspects and Clinical Significance, Annals of Medicine, vol.82, issue.3 ,
DOI : 10.1172/JCI113564
Effects of Human Recombinant Erythropoietin on Anaemia, Systemic Haemodynamics and Renal Function in Predialysis Renal Failure Patients, Nephrology Dialysis Transplantation, vol.4, issue.11, pp.966-70, 1989. ,
DOI : 10.1093/ndt/4.11.966
Erythropoietin therapy may retard progression in chronic renal transplant dysfunction, Nephrology Dialysis Transplantation, vol.17, issue.9, pp.1667-73, 2002. ,
DOI : 10.1093/ndt/17.9.1667
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial ,
Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD, Nephrol Dial Transplant, vol.7, pp.526-535, 1992. ,
Novel erythropoiesisstimulating protein (NESP) effectively maintains hemoglobin when administered at a reduced dose frequency compared with recombinant human erythropoietin in dialysis patients ,
Antibodies against recombinant human erythropoietin in a patient with erythropoietinresistant anemia ,
A case of anti-erythropoietin antibodies following recombinant human erythropietin treatment, Erythropoietin: Molecular Physiology and clinical Application ,
The effects of normal as compared with low hematocrit v alues in patients with cardiac disease who are receiv ing hemodialysis and epoetin ,
Clinical and biochemical correlates of starting ???daily??? hemodialysis, Kidney International, vol.55, issue.6, pp.2467-76, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00493.x
Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis Patients, American Journal of Nephrology, vol.4, issue.6 ,
DOI : 10.1159/000166851
une molécule d'avenir dans l'insuffisance cardiaque Synth, Med. Cardiologie, vol.68, pp.19-20, 1991. ,
WANDERS Carnitine biosynthesis in mammals, 417±429 67 -CHARLES J. REBOUCHE Kinetics, Pharmacokinetics, and Regulation of L-Carnitine and Acetyl-L-carnitine Metabolism, 2002. ,
The role of carnitine in normal and altered fatty acid metabolism, American Journal of Kidney Diseases, vol.41, issue.1, pp.4-12 ,
DOI : 10.1016/S0272-6386(03)00112-4
Activité physique et carnitine : le mythe et la réalité Méd Sport, pp.197-207, 1994. ,
Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I, Biochemical Journal, vol.214, issue.1, pp.83-91, 1983. ,
DOI : 10.1042/bj2140083
The effects of carnitine on myocardial carbonhydrate metabolism, pp.39-52, 1995. ,
Primary systemic carnitine deficiencey manifested by carnitine-responsive cardiomyopathy, pp.155-184, 1992. ,
Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure., Japanese Circulation Journal, vol.54, issue.12, pp.1471-1476, 1990. ,
DOI : 10.1253/jcj.54.12_1471
Ketogenic response to fasting in human carnitine deficiencies, Clinica Chimica Acta, vol.100, issue.3, pp.209-214, 1980. ,
DOI : 10.1016/0009-8981(80)90268-5
Carnitine metabolism in patients with chronic liver disease, Hepatology, vol.25, issue.1, pp.1579-1599, 1996. ,
DOI : 10.1053/jhep.1997.v25.pm0008985281
Carnitine metabolism in patients with chronic liver disease Hepathology, pp.148-153, 1997. ,
Utilization of Citrate, Acetylcarnitine, Acetate, Pyruvate and Glucose for the Synthesis of Acetylcholine in Rat Brain Slices, Journal of Neurochemistry, vol.36, issue.4, pp.1323-1330, 1981. ,
DOI : 10.1016/0003-2697(78)90080-5
Newer Aspects of Carnitine Metabolism in Uremia, Seminars in Nephrology, vol.26, issue.1, pp.52-55 ,
DOI : 10.1016/j.semnephrol.2005.06.010
Et al Carnitine concentration in dialysed and undialysed patients with chronic renal insufficiency, Ann. Clin. Biochem, vol.25, pp.671-675, 1986. ,
Physician's L-carnitine hemodialysis utilisation survey Dialisys Transplant, pp.513-516, 1995. ,
Italy-L-carnitine hemodialisys utilization survey Dialisys Transplant, pp.368-373, 1996. ,
Quantitative assessment of carnitine loss dureing hemodialysis and hemofiltration Kidney Int, pp.146-146, 1983. ,
Selective trophic effect of L-carnitine in type I and II a skeletal muscle fibers Kidney Int, pp.1616-1619, 1994. ,
Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients, The American Journal of Clinical Nutrition, vol.51, issue.3, pp.407-410, 1990. ,
DOI : 10.1093/ajcn/51.3.407
et al Beneficial effects of L-carnitine in post-dialysis syndrome, Curr. Ther. Res, vol.32, pp.116-127, 1982. ,
Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects, Kidney International, vol.38, issue.5, pp.904-911, 1990. ,
DOI : 10.1038/ki.1990.289
Endocrine metabolic effects of L-carnitine in patients on regular dialysis treatment Proc, EDTA, vol.19, pp.302-307, 1982. ,
Correlation between increased serum and tissue L-carnitine levels and improved ùuscle symptoms in hemodialysed patients Am, J. Diet. Assoc, vol.86, pp.644-647, 1983. ,
et al The response to recombinant human erythropoietin in patients with anemia of end stage renal disease is correlated with serum carnitine levels Nephron, pp.127-128, 1991. ,
Entry of acetyl-l-carnitine into biosynthetic pathways, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.876, issue.1, pp.175-177, 1986. ,
DOI : 10.1016/0005-2760(86)90332-2
et al Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability, Life Sci, pp.47-2395, 1990. ,
Role of carnitine and carnitine palmitoyltransferase as integral component of the pathwau for membrane phospholipid fatty acid turnover in intact human erythrocytes, J. Biol. Chem, vol.267, pp.12673-12681, 1992. ,
Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients Nephron, p.145, 1994. ,
Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients Nephron, pp.574-578, 1996. ,
Effet de la L-carnitine chez les patients en hémodialyse chronique traités par érythropoïétine recombinante Néphrologie, p.171, 1998. ,
Response to recombinant Human Erythropoietin and L-carnitine combination in patients with anemia of end stage disease Nephron, pp.314-315, 1996. ,
Anemia and carnitine supplementation in hemodialyzed patients, Kidney International, vol.55, issue.Suppl. 69, pp.93-106, 2004. ,
DOI : 10.1046/j.1523-1755.1999.055Suppl.69093.x